Thyroid Manager requires free registration
Login or Register

Category archives for Uncategorized

Relation of Stimulated Post Ablation Tg to Tumor Recurrence

Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. Kloos RT J Clin Endocrinol Metab. 2010 Dec;95(12):5241-8. Epub One hundred seven patients had initial thyroid cancer surgery and subsequent remnant radioiodine ablation. Patients underwent recombinant human TSH (rhTSH)-mediated diagnostic whole-body scan and rhTSH-stimulated thyroglobulin (Tg) measurement before […]

An Extensive Review of the Role of Selenium in Thyroid Homeostasis

Selenium and the thyroid: a close-knit connection. Duntas LH J Clin Endocrinol Metab. 2010 Dec;95(12):5180-8. Epub 2010 Sep 1. The recent recognition that the essential trace element selenium is incorporated as selenocysteine in all three deiodinases has decisively confirmed the clear-cut link between selenium and thyroid function. It has additionally been established that the thyroid […]

Making the Case for RAI Treatment of Intra-thoracic Goiter

Approach to management of the patient with primary or secondary intrathoracic goiter. Hegedüs L , Bonnema SJ J Clin Endocrinol Metab. 2010 Dec;95(12):5155-62. Intrathoracic (substernal) goiter, depending on definition, is seen in up to 45% of all patients operated for goiter. It can either be primary (ectopic thyroid tissue detached from a cervical thyroid mass), […]

Correlation of BRAF V600E mutations and tumor invaseness in papillary thyroid carcinoma

JCEM 2010, 95(9):4197-4205 Basolo et al Evaluation of the degree of neoplastic infiltration beyond the thyroid capsule remains a unique parameter that can be evaluated by histopathological examination to label a papillary thyroid carcinoma (PTC) of 20 mm or less in size as a pT1 or pT3 tumor. We correlated the BRAF V600E mutation with […]

A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: The Birmingham Elderly Thyroid study

The Birmingham Elderly Thyroid study. Parle J , Roberts L , Wilson S , Pattison H , Roalfe A , Haque MS , Heath C , Sheppard M , Franklyn J , Hobbs FD J Clin Endocrinol Metab. 2010 Aug;95(8):3623-32. Epub 2010 May 25. Subclinical hypothyroidism (SCH) and cognitive dysfunction are both common in the […]

More on Possible Adverse Effects of Subclinical Hypothyroidism

Subclinical hypothyroidism and the risk of coronary heart disease and mortality. Rodondi N , den Elzen WP , Bauer DC , Cappola AR , Razvi S , Walsh JP , Asvold BO , Iervasi G , Imaizumi M , Collet TH , Bremner A , Maisonneuve P , Sgarbi JA , Khaw KT , Vanderpump […]

Treatment of MNG with RAI

Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy. Fast S , Hegedüs L , Grupe P , Nielsen VE , Bluhme C , Bastholt L , Bonnema SJ J Clin Endocrinol Metab. 2010 Aug;95(8):3719-25. Epub 2010 Jun 2. Stimulation with recombinant human TSH (rhTSH) before […]

Radiation Exposure During Remnant Ablation

Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal. Taieb D , Sebag F , Farman-Ara B , Portal T , Baumstarck-Barrau K , Fortanier C , Bourrelly M , Mancini J , De Micco C , Auquier P , Conte-Devolx B , Henry JF , Mundler […]

More Reports on Tyrosine kinase Ihibitors in Thyroid Cancer

Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. Cabanillas ME , Waguespack SG , Bronstein Y , Williams MD , Feng L , Hernandez M , Lopez A , Sherman SI , Busaidy NL J Clin Endocrinol Metab. 2010 Jun;95(6):2588-95. Epub 2010 Apr 14. Cabanillas et al […]

Treatment of extremely low gestational age neonates (ELGANS) with thyroid hormone

TOPIC: Treatment of transient hypothyroxinemia of prematurity Title: Phase 1 trial of four thyroid hormone regimens for transient hypothyroxinemia in neonates of less than 28 weeks’ gestation . Authors: La Gamma EF, van Wassenaer AG, Ares S, Golumbek SG, Kok JH, Quero J, Hong T, Rahbar MH, Morreale de Escobar G, Fisher DA, & Paneth […]

Development of orally active agonists of the TSH receptor

TOPIC: TSH receptor Title: Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice. Authors: Neumann S, Huang W, Titus S, Krause G, Kleinau G, Alberobello AT, Zheng W, Southall NT, Inglese J, Austin CP, Celi FS, Gavrilova O, Thomas CT, Raaka BM, & Gershengorn MC . Reference: Proc. Natl. Acad. […]

Complete resistance to TRH in a family

TOPIC: A biologically inactive TRH due to a mutant TRH-receptor Title: A family with complete resistance to thyrotropin-releasing hormone Authors: Bonomi M, Busnelli M, Beck-Peccoz P, Constanzo D, Antonica F, & Dolci C. Reference: New England Journal of Medicine 360: 731-734, 2009 Summary Background Recessive resistance to the action of TRH is a rare disorder […]

Management of well-differentiated thyroid cancer prior to radioiodine ablation

TOPIC: The importance of pre-ablation RAI scans Title: The utility of radioiodine scans prior to I131 ablation in patients with well-differentiated thyroid cancer Authors: Van Nostrand D, Aiken M, Atkins F, Moreau S, Garcia C, Acio E, Burman K, & Wartofsky L. Reference: Thyroid 2009 March 13 [Epub ahead of print] Summary Background The utility […]

Title: Side effects of tyrosine kinase inhibitors

* Second of a new series of ‘Mini-Editorials’ in ‘Thyroid News’ While accounting for only 1% of solid malignancies, thyroid carcinoma is the most common malignancy of the endocrine system. The majority are patients with well-differentiated thyroid carcinoma of follicular cell origin who are cured with adequate surgical management and radioiodine therapy. However, some thyroid […]

T helper cell subsets in autoimmune thyroid disease

TOPIC: A role for Th17 T cells in AITD Title: Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Authors: Nanba T , Watanabe M , Inoue N , & Iwatani Y . Reference: Thyroid 19: 495-501, 2009 Summary Background CD4+ T cells […]

Changes in thyroid cancer incidence are mainly related to better detection sensitivity of microcarcinomas

TOPIC: Incidence of thyroid cancer in France (1998-2006) Title: Thyroid cancer: is the incidence rise abating? Authors: Sassolas G, Hafdi-Nejjari Z, Remontet L, Bossard N, Belot A, Berger-Dutrieux N, Decaussin-Petrucci M, Bournaud C, Peix zithromax online JL, Orgiazzi J, Borson-Chazot F, and the ‘Group of Pathologists’ of the Rhône-Alpes Region. Reference: European Journal of Endocrinology […]

Rightward shift in serum TSH range in individuals with exceptional longevity

TOPIC: TSH reference range increases with aging Title: Extreme longevity is associated with increased serum thyrotropin. Authors: Atzmon G, Barzilai N, Hollowell JG, Surks MI, & Gabriely I. Reference: Journal of Clinical Endocrinology & Metabolism 94: 1251-1254, 2009 Summary Context The TSH reference range, specifically the setting of the upper reference limit, is currently controversial. […]

Cigarette smoking and pregnancy

TOPIC: Thyroid function in pregnancy Title: Cigarette smoking during pregnancy is associated with alterations in maternal and fetal thyroid function. Authors: Shields B, Hill A, Bilous M, Knight B, Hattersley AT, Bilous RW, & Vaidya B. Reference: Journal of Clinical Endocrinology & Metabolism 94: 570-574, 2009 Summary Background Studies in the general population have shown […]

Adverse cardiovascular events in AIT

TOPIC: Amiodarone-induced thyrotoxicosis Title: Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome . Authors: Yiu K-H, Jim M-H, Lee C-H, Yuen M, Mok M, Shea Y-F, Fan K, Tse H-F, & Chow W-H. Reference: Journal of Clinical Endocrinology and Metabolism 94: 109-114, 2009 Summary Background Whether the risk of long-term major adverse cardiovascular events […]

Graves disease in children

TOPIC: Predictors of relapse in pediatric Graves’ disease Title: Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. Authors: Kaguelidou F, Alberti C, Castanet M, Guitteny M-A, Czernichow P, Léger J (the French childhood Graves’ disease study group) Reference: Journal of Clinical Endocrinology & Metabolism93: 3817–3826, 2008 There is debate about […]

Thyroid hormone transport into the brain

TOPIC: Role of membrane transporters of thyroid hormone on their transfer into the brain Title: Expression of the thyroid hormone transporter MCT8 (SLC16A2) and AOTP14 (SLC01C1) at the blood-brain barrier. Authors: Roberts LM, Woodford K, Zhou M, Black DS, et al. Reference: Endocrinology 149: 6251-6261, 2008 Summary Background Thyroid hormones require transport across cell membranes […]

Thyroid autoimmunity

TOPIC: Use of Pendrin antibody measurement in AITD Title: Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. Authors: Yoshida A, Hisatome I, Taniguchi S, Shirayoshi Y, et al. Reference: Journal of Clinical Endocrinology & Metabolism94: 442-448, 2009 Context Pendrin is an apical protein of thyroid follicular cells, responsible for the efflux […]